John Lissoway

John Lissoway practices at Presbyterian Hospital in Albuquerque, New Mexico, part of Presbyterian Healthcare Services.

John Lissoway's NPI, 1669673695, was assigned on May 29, 2007. John Lissoway graduated from University of New Mexico School of Medicine in 2007. John Lissoway holds New Mexico license MD2012-0752.

John Lissoway's primary practice is Presbyterian Hospital, at 1100 Central Avenue SE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 724-8386.

John Lissoway's primary practice is Presbyterian Hospital in Albuquerque, New Mexico, part of Presbyterian Healthcare Services. The medical group on file is Presbyterian Medical Group. Dmand AI also links John Lissoway to 1 more group practice or clinic, named with a free account. John Lissoway's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where John Lissoway practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is John Lissoway's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dmand AI has John Lissoway's licenses on file in 2 states: New Mexico and Florida.

CMS data shows 109 Medicare services from John Lissoway across 3 procedure codes in 2024, for 118 Medicare patients. Medicare paid $13,437 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 118 Medicare patients who saw John Lissoway in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 41% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts John Lissoway's median patient age at 50, with 54% women.

In 2024, John Lissoway wrote 72 Medicare Part D claims for 57 patients. 92% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $73 in total drug cost. In 2022, CMS named 24 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for John Lissoway for performance year 2024, reported as part of a group. John Lissoway accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to John Lissoway from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $16.

John Lissoway graduated from University of New Mexico School of Medicine in 2007.